Just in: Business leader battling ALS passes title to wife
Her career with the #Dayton company followed her retirement as vice president at Procter & Gamble – where she executed a ...
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
Progress spurred by ALS Ice Bucket Challenge — and what remains to be done 10 years later
The brainchild of two ALS sufferers, the Ice Bucket Challenge took off in August 2014 — and the initiative is still having an ...
Medscape7d
ALS Trials Fail to Meet Key Endpoints…But It’s Still a Win and Here’s Why
While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...
Blood test can help diagnose, track ALS patients, French study indicates
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Hosted on MSN3d
Novel Agent Safe in ALS, Phase II Study Suggests
Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...
Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
News Medical21m
Stress granules as potential biomarkers for neurodegenerative diseases
Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
Inside the Manhattan Home Where Legendary Singer Roberta Flack Passed Away at Age 88
Legendary "If Ever I See You Again" singer Roberta Flack has passed away at the age of 88 at her home in Manhattan surrounded ...
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
DiagnaMed Holdings Corp.: DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...